Metabolomic analysis identifies the regulation of lipid metabolism pathway as potential mechanisms of Jiangzhi decoction against non-alcoholic fatty liver disease
Journal of Pharmacy and Pharmacology · 2023
DOI: 10.1093/jpp/rgad067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Lei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, 358 Datong Road, Pudong, Shanghai 200137, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Drugs, Chinese Herbal, Lipid Metabolism. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission, Talents Training Program of Pudong Health Commission of Shanghai.
Abstract (Originalsprache)
Objectives
To illustrate the metabolic regulatory mechanisms of Jiangzhi decoction (JZD) against non-alcoholic fatty liver disease (NAFLD).
Methods
High-fat diet (HFD)-induced NAFLD rats were treated with JZD. The pathological morphology, lipid indexes and liver function were detected. Metabolic profiles were examined by liquid chromatography–mass spectrometry (LC–MS). Multivariate and univariate statistical analysis were used to search the differential metabolites. Pathway enrichment analysis was carried out using Kyoto Encyclopedia of Genes and Genomes database. Compound-gene networks were built by Cytoscape software.
Results
JZD significantly alleviated the pathological conditions and improved lipid index levels. Multivariate analysis showed a good separation among different groups. Three hundred and twenty-seven metabolites in HFD versus control and 301 metabolites in JZD versus HFD were identified to be significantly different. Pathway enrichment analysis showed that lipid metabolism pathways were prominent altered pathways. Importantly, the relationships were more distant between JZD and HFD groups in all five lipid metabolism pathways, including arachidonic acid metabolism, linoleic acid metabolism, biosynthesis of unsaturated fatty acids, glycerophospholipid metabolism and sphingolipid metabolism, while those were obviously closer between JZD and control groups. Simultaneously, JZD treatment restored the levels of disturbed differential metabolites in HFD group.
Conclusion
JZD had an effect on alleviating NAFLD via regulating relevant lipid metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, 358 Datong Road, Pudong, Shanghai 200137, China.
ORCID-Profile: Yanan Song
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission
- Talents Training Program of Pudong Health Commission of Shanghai
Zitieren
APA
Wang, L., Zhi, Y., Ye, Y., Zhang, M., Mai, Z., Xia, W., & Song, Y. (2023). Metabolomic analysis identifies the regulation of lipid metabolism pathway as potential mechanisms of Jiangzhi decoction against non-alcoholic fatty liver disease. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad067
Vancouver
Wang L, Zhi Y, Ye Y, Zhang M, Mai Z, Xia W, et al. Metabolomic analysis identifies the regulation of lipid metabolism pathway as potential mechanisms of Jiangzhi decoction against non-alcoholic fatty liver disease. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad067
BibTeX
@article{Wang2023,
author = {Wang, Lei and Zhi, Yin and Ye, Ying and Zhang, Miao and Mai, Zhongchao and Xia, Wei and Song, Yanan},
title = {Metabolomic analysis identifies the regulation of lipid metabolism pathway as potential mechanisms of Jiangzhi decoction against non-alcoholic fatty liver disease},
journal = {Journal of Pharmacy and Pharmacology},
year = {2023},
doi = {10.1093/jpp/rgad067}
}
EUVIMED